Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Sun.
Press releases published on June 2, 2025
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
GlobeNewswire
·
June 2, 2025
REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies …
Diana Shipping Inc. Announces Time Charter Contract for m/v Newport News With Bohai Ocean Shipping
GlobeNewswire
·
June 2, 2025
ATHENS, Greece, June 02, 2025 (GLOBE NEWSWIRE) -- Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate wholly-owned …
High Grade Ni/PGE Adjoining Globex’s Tyrone Property
GlobeNewswire
·
June 2, 2025
ROUYN-NORANDA, Quebec, June 02, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …
Evosep unveils new instrumentation and partnership at ASMS 2025
GlobeNewswire
·
June 2, 2025
BALTIMORE, Md., June 02, 2025 (GLOBE NEWSWIRE) -- Evosep®, a global leader in proteomics solutions, is proud to announce the launch of the Evosep Eno™, a robust, high-throughput separation tool preparing for next generation workflow integration for LC-MS …
AB Akola Group presentation during the Nasdaq Vilnius Stock Exchange’s traditional event, “CEO Meets Investors”
GlobeNewswire
·
June 2, 2025
On June 2, 2025, AB Akola Group's CFO, Mažvydas Šileika, shared a slide presentation with the investment community during the Nasdaq Vilnius Stock Exchange’s traditional event, “CEO Meets Investors”. Attached: presentation demonstrated during the event. …
AB Akola group pristatymas Nasdaq Vilniaus vertybinių popierių biržos renginio „Vadovai susitinka su investuotojais“ metu
GlobeNewswire
·
June 2, 2025
2025 m. birželio 2 d. AB Akola group finansų direktorius Mažvydas Šileika atliko pristatymą investuotojų bendruomenei tradicinio Nasdaq Vilniaus vertybinių popierių biržos renginio „Vadovai susitinka su investuotojais“ metu. Pridėta: renginio metu rodytos …
Oxylabs Unveils First-of-its-kind YouTube Datasets to Power Responsible AI
GlobeNewswire
·
June 2, 2025
The datasets fast-track video data from creator consent to AI-readiness VILNIUS, Lithuania, June 2, 2025 – Oxylabs, a leading web intelligence platform and proxy provider, introduces industry-first YouTube datasets composed entirely of consent-based data. …
Full Dose-Escalation Data Show Continued High Response Rates and Favorable Safety Profile of ISB 2001, a First-in-Class BCMA × CD38 × CD3 Trispecific Antibody, for the Treatment of Relapsed/Refractory Multiple Myeloma
GlobeNewswire
·
June 2, 2025
TRIgnite-1 study shows an overall response rate (ORR) of 74% across nine dose levels, in heavily pretreated patients with a median of six prior lines of therapy ORR is remarkably high in patients with no prior CAR-T or bispecific therapies (84%) as well as …
Sébastien Jacquet Appointed Chief Quality Officer
GlobeNewswire
·
June 2, 2025
Sébastien Jacquet Appointed Chief Quality Officer AMSTERDAM, June 2, 2025 – Stellantis N.V. today announced the appointment of Sébastien Jacquet as Chief Quality Officer, effective immediately. He succeeds Antonio Filosa, who has been appointed to be the …
Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update
GlobeNewswire
·
June 2, 2025
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel DNA-damage response (DDR) cancer therapies powered by artificial …
Robex Reports Operational and Financial Results for Q1 2025
GlobeNewswire
·
June 2, 2025
QUÉBEC CITY, June 02, 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX/ASX: RXR) Matthew Wilcox, Managing Director, commented: "The company has had a strong start to 2025, construction continues to advance at Kiniero, and …
Fancamp Announces Appointment of CIO
GlobeNewswire
·
June 2, 2025
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce the appointment of Mr. Kit Spring to the position of Chief Investment Officer (“CIO …
Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
31% confirmed ORR (8 responses in 26 evaluable patients) across B7-H4 high tumors at intermediate doses 44% confirmed ORR (7 responses in 16 evaluable patients) in the subset of patients with ≤4 prior lines of therapy CAMBRIDGE, Mass., June 02, 2025 (GLOBE …
COS Systems expands Open Access Services partnership with Fujitsu
EIN Presswire
·
June 2, 2025
Extended partnership enables turn-key Open Access network operations backed by COS Business Engine. WEST PALM BEACH, FL, UNITED STATES, June 1, 2025 /EINPresswire.com/ -- COS Systems continues to strengthen its partnership with Fujitsu, a leading …
ASML reports transactions under its current share buyback program
GlobeNewswire
·
June 2, 2025
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …
STMicroelectronics Announces Status of Common Share Repurchase Program
GlobeNewswire
·
June 2, 2025
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from May 26, 2025 to May 30, 2025 AMSTERDAM – June 2, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global …
Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICML
GlobeNewswire
·
June 2, 2025
Presentation at the International Conference on Malignant Lymphoma (ICML) in Lugano on June 21 SIDNEY is an ongoing Phase 2 trial of EO2463 in 48 indolent Non-Hodgkin Lymphoma (iNHL) patients Enterome has held a positive Type-C meeting with FDA for …
Allarity Therapeutics Announces First Patient Enrolled in New Phase 2 Clinical Trial Protocol of Stenoparib in Advanced Ovarian Cancer
GlobeNewswire
·
June 2, 2025
TARPON SPRINGS, Fla., June 2, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway …
SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m Frequency – NEW YORK, June 02, 2025 (GLOBE …
Aventis Energy Announces Appointment of Michael Mulberry to the Board of Directors
GlobeNewswire
·
June 2, 2025
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF), is pleased to announce that Mr. Michael Mulberry has been appointed to the board of directors of the …